GLIPDEN-2

Description

GLIPDEN-2 contains Glimepiride 2 mg in tablet form. Glimepiride is an oral antidiabetic medicine belonging to the sulfonylurea class. It helps lower blood glucose by stimulating the pancreas to release insulin. GLIPDEN-2 may be prescribed for adults with type 2 diabetes mellitus when diet, exercise and an individualized diabetes-care plan require additional blood glucose control.

For related diabetic and cardiovascular formulations, explore the Medhexa Pharma Cardries Biotic range for additional pharmaceutical products and business enquiries.

Therapeutic Segment

Anti-Diabetic Therapy | Type 2 Diabetes Management | Sulfonylureas | Oral Antidiabetic Therapy | Blood Glucose Control

Uses of GLIPDEN-2

GLIPDEN-2 may be prescribed as part of a comprehensive treatment plan for:

• Type 2 diabetes mellitus
• Inadequate blood glucose control with diet and exercise
• Patients requiring sulfonylurea therapy
• Improving glycaemic control when additional oral antidiabetic treatment is required
• Blood glucose management as part of an individualized diabetes-care plan

Glimepiride is intended for type 2 diabetes and should not be used for the treatment of type 1 diabetes or diabetic ketoacidosis.

Key Benefits of GLIPDEN-2

• Blood glucose support: Helps lower blood glucose in adults with type 2 diabetes.
• Sulfonylurea therapy: Stimulates pancreatic beta cells to release insulin.
• Supports glycaemic control: Can contribute to improved blood glucose management when prescribed appropriately.
• 2 mg strength: Provides a defined Glimepiride dose in tablet form.
• Oral formulation: Convenient tablet dosage form for prescribed diabetes therapy.
• Individualized treatment: The dose can be adjusted by a healthcare professional according to blood glucose response and tolerability.

How GLIPDEN-2 Works

Glimepiride belongs to the sulfonylurea class of oral antidiabetic medicines.

It acts primarily on pancreatic beta cells and stimulates the release of insulin. The increased availability of insulin helps glucose move from the bloodstream into tissues, thereby lowering blood glucose levels.

Glimepiride can also improve the body’s response to insulin to some extent. Its glucose-lowering effect depends on the presence of functioning pancreatic beta cells.

Common Side Effects of GLIPDEN-2

Glimepiride can cause side effects, particularly those related to its blood glucose-lowering action. Possible effects include:

• Hypoglycaemia
• Headache
• Dizziness
• Nausea
• Abdominal discomfort
• Weakness
• Weight gain
• Skin rash

Hypoglycaemia represents an important potential adverse effect of Glimepiride. The risk can increase when meals are skipped, food intake is inadequate, alcohol is consumed or Glimepiride is combined with other glucose-lowering medicines.

Seek urgent medical attention for severe hypoglycaemia, confusion, seizures, loss of consciousness or other serious symptoms.

Important Safety Information

Use GLIPDEN-2 only according to the advice of a qualified healthcare professional.

• Monitor blood glucose regularly as recommended by your diabetes-care team.
• Hypoglycaemia: Glimepiride can cause low blood glucose. Keep the timing and quantity of meals consistent according to your healthcare professional’s advice.
• Avoid skipping meals while taking Glimepiride unless your healthcare professional specifically advises otherwise.
• Excessive alcohol consumption can increase the risk of hypoglycaemia and affect blood glucose control.
• Tell your doctor if you have kidney or liver disease, as these conditions can affect the safety and response to Glimepiride.
• Older adults and patients with reduced kidney function may require careful dose selection because prolonged or severe hypoglycaemia can occur.
• Tell your healthcare professional if you have G6PD deficiency, as sulfonylurea medicines may increase the risk of haemolytic anaemia in susceptible individuals.
• Inform your doctor about all prescription medicines, over-the-counter medicines, vitamins and supplements you take because several medicines can alter blood glucose control or Glimepiride’s effects.
• Tell your doctor if you are taking other antidiabetic medicines, beta-blockers or medicines that may affect blood glucose.
• Beta-blockers and some other medicines may mask certain warning symptoms of hypoglycaemia.
• Discuss pregnancy or breastfeeding with your healthcare professional before using Glimepiride.
• Do not change the dose or stop diabetes treatment without medical advice.
• Continue appropriate diet, physical activity and blood glucose monitoring as recommended.
• Keep GLIPDEN-2 out of the reach of children.

For additional information about Glimepiride and its use in diabetes management, refer to the DailyMed prescribing information for Glimepiride.

Dosage & Administration

Take GLIPDEN-2 exactly as prescribed by your healthcare professional.

The appropriate Glimepiride dose depends on the patient’s blood glucose levels, previous diabetes treatment, kidney and liver function, diet and response to therapy.

For adults who require Glimepiride, healthcare professionals generally start with a low dose and adjust it gradually according to blood glucose response and tolerability. The exact dose and adjustment schedule should follow the approved product information and individual prescription.

Glimepiride is generally taken with breakfast or the first main meal of the day. Take the tablet with water and follow the administration instructions provided by your healthcare professional.

Do not increase the dose if blood glucose remains elevated. If you miss a dose, follow your healthcare professional’s instructions rather than taking a double dose.

Storage

• Store GLIPDEN-2 in a cool, dry place.
• Protect the tablets from excessive heat and moisture.
• Keep the tablets away from direct sunlight.
• Keep the tablets in their original ALU-ALU packaging until use.
• Keep out of the sight and reach of children.
• Do not use the product after the expiry date printed on the packaging.